CN103308681A - 胰蛋白酶原-2检测试剂盒及制备方法 - Google Patents
胰蛋白酶原-2检测试剂盒及制备方法 Download PDFInfo
- Publication number
- CN103308681A CN103308681A CN2013102537191A CN201310253719A CN103308681A CN 103308681 A CN103308681 A CN 103308681A CN 2013102537191 A CN2013102537191 A CN 2013102537191A CN 201310253719 A CN201310253719 A CN 201310253719A CN 103308681 A CN103308681 A CN 103308681A
- Authority
- CN
- China
- Prior art keywords
- trypsinogen
- reagent
- latex
- antibody
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 85
- 238000001514 detection method Methods 0.000 title claims abstract description 73
- 239000004816 latex Substances 0.000 claims abstract description 162
- 229920000126 latex Polymers 0.000 claims abstract description 162
- 239000002245 particle Substances 0.000 claims abstract description 125
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 76
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 27
- 239000006177 biological buffer Substances 0.000 claims abstract description 23
- 239000003755 preservative agent Substances 0.000 claims abstract 3
- 230000002335 preservative effect Effects 0.000 claims abstract 3
- 239000000243 solution Substances 0.000 claims description 105
- 238000006243 chemical reaction Methods 0.000 claims description 81
- 239000004005 microsphere Substances 0.000 claims description 52
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 claims description 41
- 238000003756 stirring Methods 0.000 claims description 41
- 238000013016 damping Methods 0.000 claims description 39
- 239000012530 fluid Substances 0.000 claims description 39
- 239000012153 distilled water Substances 0.000 claims description 37
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 23
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical group OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 21
- 230000002421 anti-septic effect Effects 0.000 claims description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 18
- 239000006228 supernatant Substances 0.000 claims description 18
- 238000005406 washing Methods 0.000 claims description 14
- 239000008367 deionised water Substances 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 12
- 150000001718 carbodiimides Chemical class 0.000 claims description 11
- 239000011259 mixed solution Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 230000005540 biological transmission Effects 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 239000008187 granular material Substances 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000005259 measurement Methods 0.000 abstract description 2
- 238000010382 chemical cross-linking Methods 0.000 abstract 1
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- 238000012360 testing method Methods 0.000 description 23
- 238000004321 preservation Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 12
- 102000018690 Trypsinogen Human genes 0.000 description 9
- 108010027252 Trypsinogen Proteins 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical class CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 7
- 239000004793 Polystyrene Substances 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- -1 dimethylaminopropyl Chemical group 0.000 description 7
- 229920002223 polystyrene Polymers 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 239000013049 sediment Substances 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 102000013142 Amylases Human genes 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 206010033645 Pancreatitis Diseases 0.000 description 4
- 206010033647 Pancreatitis acute Diseases 0.000 description 4
- 201000003229 acute pancreatitis Diseases 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000003547 immunosorbent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000007743 Acute Abdomen Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000010558 Gene Alterations Effects 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 206010033654 Pancreatitis necrotising Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 1
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310253719.1A CN103308681B (zh) | 2013-06-25 | 2013-06-25 | 胰蛋白酶原-2检测试剂盒及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310253719.1A CN103308681B (zh) | 2013-06-25 | 2013-06-25 | 胰蛋白酶原-2检测试剂盒及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103308681A true CN103308681A (zh) | 2013-09-18 |
CN103308681B CN103308681B (zh) | 2015-07-29 |
Family
ID=49134127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310253719.1A Active CN103308681B (zh) | 2013-06-25 | 2013-06-25 | 胰蛋白酶原-2检测试剂盒及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103308681B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103529225A (zh) * | 2013-11-04 | 2014-01-22 | 武汉华美生物工程有限公司 | 一种肝型脂肪酸结合蛋白含量检测试剂盒及其制备方法 |
CN104111335A (zh) * | 2013-11-13 | 2014-10-22 | 唐勇 | 胃蛋白酶原i/ii胶乳增强免疫比浊法测定试剂盒 |
CN104808002A (zh) * | 2015-04-17 | 2015-07-29 | 南京格耀生物科技有限公司 | 一种急症腹痛早期筛查的蛋白芯片及其制备方法和应用 |
CN104820099A (zh) * | 2015-04-14 | 2015-08-05 | 南京格耀生物科技有限公司 | 一种同时检测血浆中TPSⅡ、SSA、hs-CRP、PCT和抵抗素含量的试剂盒及其应用 |
CN107589266A (zh) * | 2017-08-09 | 2018-01-16 | 上海原科实业发展有限公司 | 一种血管内皮生长因子胶乳增强免疫比浊试剂盒及其应用 |
CN109975545A (zh) * | 2019-03-22 | 2019-07-05 | 芜湖森爱驰生物科技有限公司 | 一种高准确性胃蛋白酶原ⅱ检测试剂盒 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030087458A1 (en) * | 2001-11-02 | 2003-05-08 | Lawrence Christopher C | Particles for immunoassays and methods for treating the same |
CN102998445A (zh) * | 2012-12-12 | 2013-03-27 | 元升生物科技(上海)有限公司 | 一种测定甘胆酸的试剂及制备方法 |
CN103048464A (zh) * | 2012-10-17 | 2013-04-17 | 武汉生之源生物科技有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒及其制备方法 |
CN103123319A (zh) * | 2012-12-20 | 2013-05-29 | 武汉生之源生物科技有限公司 | 心型脂肪酸结合蛋白含量检测试剂盒及其制备方法 |
-
2013
- 2013-06-25 CN CN201310253719.1A patent/CN103308681B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030087458A1 (en) * | 2001-11-02 | 2003-05-08 | Lawrence Christopher C | Particles for immunoassays and methods for treating the same |
CN103048464A (zh) * | 2012-10-17 | 2013-04-17 | 武汉生之源生物科技有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒及其制备方法 |
CN102998445A (zh) * | 2012-12-12 | 2013-03-27 | 元升生物科技(上海)有限公司 | 一种测定甘胆酸的试剂及制备方法 |
CN103123319A (zh) * | 2012-12-20 | 2013-05-29 | 武汉生之源生物科技有限公司 | 心型脂肪酸结合蛋白含量检测试剂盒及其制备方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103529225A (zh) * | 2013-11-04 | 2014-01-22 | 武汉华美生物工程有限公司 | 一种肝型脂肪酸结合蛋白含量检测试剂盒及其制备方法 |
CN104111335A (zh) * | 2013-11-13 | 2014-10-22 | 唐勇 | 胃蛋白酶原i/ii胶乳增强免疫比浊法测定试剂盒 |
CN104820099A (zh) * | 2015-04-14 | 2015-08-05 | 南京格耀生物科技有限公司 | 一种同时检测血浆中TPSⅡ、SSA、hs-CRP、PCT和抵抗素含量的试剂盒及其应用 |
CN104808002A (zh) * | 2015-04-17 | 2015-07-29 | 南京格耀生物科技有限公司 | 一种急症腹痛早期筛查的蛋白芯片及其制备方法和应用 |
CN107589266A (zh) * | 2017-08-09 | 2018-01-16 | 上海原科实业发展有限公司 | 一种血管内皮生长因子胶乳增强免疫比浊试剂盒及其应用 |
CN109975545A (zh) * | 2019-03-22 | 2019-07-05 | 芜湖森爱驰生物科技有限公司 | 一种高准确性胃蛋白酶原ⅱ检测试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN103308681B (zh) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103308681B (zh) | 胰蛋白酶原-2检测试剂盒及制备方法 | |
CN102590524B (zh) | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 | |
CN101769932B (zh) | 全量程c反应蛋白检测试剂盒 | |
CN104049085B (zh) | 一种crp胶乳增强免疫比浊测定试剂及其试剂盒 | |
CN106932589A (zh) | 测定人体血清视黄醇结合蛋白含量的试剂盒及其制备方法 | |
CN109085333A (zh) | 一种类风湿因子抗原的制备、检测试剂盒及制备方法 | |
CN104237522A (zh) | 脂联素含量检测试剂盒及其制备方法 | |
CN106568978A (zh) | 血清淀粉样蛋白a检测方法及试剂 | |
CN106353507A (zh) | 一种检测血清淀粉样蛋白的试剂盒及其用途 | |
CN108333360A (zh) | 胃泌素释放肽前体稀释液及其应用和试剂盒 | |
CN111057150B (zh) | 一种乳胶微球及其应用以及糖化血红蛋白检测试剂盒 | |
CN103645323A (zh) | 一种胱抑素c检测试剂盒及其制备方法 | |
CN102662064A (zh) | 检测中性粒细胞明胶酶相关脂质运载蛋白的免疫比浊试剂盒及其制备方法 | |
CN102901810A (zh) | 包被有前列腺特异性抗原抗体的胶乳颗粒的制备方法及psa胶乳增强免疫比浊法检测试剂盒 | |
CN110806487A (zh) | 一种用于人肝素结合蛋白检测的试剂盒及其制备方法 | |
US20240003887A1 (en) | Free prostate specific antigen measurement kit and preparation method therefor | |
CN106771152A (zh) | 一种快速检测钙卫蛋白的试剂盒 | |
CN108627652B (zh) | 一种基于单粒径并可同时检测血清和尿液样本中视黄醇结合蛋白的试剂盒 | |
Liu et al. | Procalcitonin measurement using antibody-conjugated fluorescent microspheres distinguishes atypical bacterial meningitis from viral encephalitis in children | |
CN112255421B (zh) | 一种脂蛋白a检测试剂盒及检测方法 | |
CN112698034B (zh) | 一种癌胚抗原cea的检测试剂盒 | |
CN111999505B (zh) | 检测抗链球菌溶血素o的试剂及其制备方法 | |
CN103529225B (zh) | 一种肝型脂肪酸结合蛋白含量检测试剂盒及其制备方法 | |
CN113049836A (zh) | 一种组合物及其脂联素检测试剂盒 | |
CN107942068A (zh) | β2‑微球蛋白测定试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 430223 B11 building, No. 818, hi tech medical center, hi tech Avenue, East Lake Development Zone, Wuhan, Hubei, 2 Patentee after: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Address before: 430223 Hubei city of Wuhan province East Lake Development Zone Road, University of Wuhan University of science and Technology Park building four floor Patentee before: Wuhan Life Origin Biotech Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Trypsinogen-2 detection kit and preparation method thereof Effective date of registration: 20180612 Granted publication date: 20150729 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: 2018420000024 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190620 Granted publication date: 20150729 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: 2018420000024 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Trypsinogen-2 detection kit and preparation method thereof Effective date of registration: 20191107 Granted publication date: 20150729 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co., Ltd. Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: Y2019420000025 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201223 Granted publication date: 20150729 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK Co.,Ltd. Registration number: Y2019420000025 |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 430000 1 / F, 2 / F and 3 / F, B11, hi tech medical device Park, 818 Gaoxin Avenue, Donghu Development Zone, Wuhan, Hubei Province Patentee after: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK Co.,Ltd. Address before: 2 / F, B11, Gaoke medical instrument Park, 818 Gaoxin Avenue, Donghu Development Zone, Wuhan, Hubei 430223 Patentee before: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK Co.,Ltd. |